Ceramides during Pregnancy and Obstetrical Adverse Outcomes.
Maria LantzanakiTheofanis VavilisVikentia C HarizopoulouHelen BiliDimitrios G GoulisDimitrios VavilisPublished in: Metabolites (2023)
Ceramides are a group of sphingolipids located in the external plasma membrane layer and act as messengers in cellular pathways such as inflammatory processes and apoptosis. Plasma ceramides are biomarkers of cardiovascular disease, type 2 diabetes mellitus, Alzheimer's disease, various autoimmune conditions and cancer. During pregnancy, ceramides play an important role as stress mediators, especially during implantation, delivery and lactation. Based on the current literature, plasma ceramides could be potential biomarkers of obstetrical adverse outcomes, although their role in metabolic pathways under such conditions remains unclear. This review aims to present current studies that examine the role of ceramides during pregnancy and obstetrical adverse outcomes, such as pre-eclampsia, gestational diabetes mellitus and other complications.
Keyphrases
- cardiovascular disease
- oxidative stress
- systematic review
- pregnant women
- multiple sclerosis
- type diabetes
- endoplasmic reticulum stress
- risk factors
- papillary thyroid
- cardiovascular risk factors
- cell death
- squamous cell carcinoma
- metabolic syndrome
- adipose tissue
- cognitive decline
- squamous cell
- human milk
- signaling pathway
- stress induced
- drug induced
- pregnancy outcomes
- preterm birth